Tranexamic Acid Use in Elective Cesarea… | Clinical Trial

Key information

Conditions

Placenta Previa Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Placenta Diseases Pregnancy Complications Urogenital Diseases

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

About this study

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa to detect efficacy of Tranexamic acid in decreasing blood loss

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Term pregnancy (more than 37 weeks of gestation)
Diagnosis of placenta previa was confirmed by ultrasound
The patient hemoglobin percentage is more than 10 mg/dl

Exclusion criteria

Invading placenta previa diagnosis was confirmed by Doppler ultrasound studies
Emergency lower segment cesarean section
Associated medical comorbidities

Treatment and study plan

Tranexamic Acid

Drug

10 mg/kg body weight will be given with induction of anesthesia by intravenous infusion

Primary outcomes

intra operative blood loss in ml

Time frame: intraoperative during cesarean section

Calculation of blood loss during cesarean section in the two groups to detect efficacy of Tranexamic acid in reducing blood loss

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa: A Randomized Controlled Trial

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2016
First posted: Feb 23, 2017
Registry last updated: Feb 23, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed